1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ
(eds) (2017) World Health Organization classification of head and
neck tumours, 4th edn. IARC, Lyon, pp 108–111
2. Elder DE, Massi D, Scolyer RA, Willemze R (eds) (2018) World
Health Organization classification of skin tumours, 4th edn.
IARC, Lyon, pp 43–44
3. Kuo T (1980) Clear cell carcinoma of the skin. A variant of the
squamous cell carcinoma that simulates sebaceous carcinoma.
Am J Surg Pathol 4:573–583. https://d oi.o rg/1 0.1 097/0 0000
478-198012000-00008
4. Frazier JJ, Sacks H, Freedman PD (2012) Primary glycogenrich clear cell squamous cell carcinoma of the mandibular gingiva. Oral Surg Oral Med Oral Pathol Oral Radiol 114:e47–e51.
https://doi.org/10.1016/j.oooo.2012.01.033
5. Corbalán-Vélez R, Ruiz-Macia JA, Brufau C, López-Lozano JM,
Martínez-Barba E, Carapeto FJ (2009) Clear cells in cutaneous
squamous cell carcinoma. Actas Dermosifiliogr 100:307–316.
https://doi.org/10.1016/S1578-2190(09)70068-X
6. Cipriani NA, Kakkar A (2023) Top 10 clear cell head and neck
lesions to contemplate. Head Neck Pathol 17:33–52. https://doi.
org/10.1007/s12105-022-01518-6
7. Kumar K, Shetty DC, Wadhwan V, Gupta P (2012) Synchronous
oral squamous cell carcinomas with unusual histopathological
feature. J Oral Maxillofac Pathol 16:420–424. https://doi.org/
10.4103/0973-029X.102506
8. Nainani P, Singh HP, Paliwal A, Nagpal N (2014) A rare case
report of clear cell variant of oral squamous cell carcinoma. J
Clin Diagn Res 8:QD07–QD09. https://doi.org/10.7860/JCDR/
2014/11536.5339
9. Kaliamoorthy S, Sethuraman V, Ramalingam SM, Arunkumar
S (2015) A rare case of clear cell variant of oral squamous cell
carcinoma. J Nat Sci Biol Med 6:245–247. https://doi.org/10.
4103/0976-9668.149209
10. Khoury ZH, Bugshan A, Lubek JE, Papadimitriou JC, Basile
JR, Younis RH (2017) Glycogen-rich clear cell squamous cell
carcinoma originating in the oral cavity. Head Neck Pathol
11:552–560. https://doi.org/10.1007/s12105-017-0812-3
11. Devi A, Kamboj M, Singh V, Singh S (2017) Clear-cell variant
of squamous cell carcinoma in maxilla as primary lesion: a rare
case. J Oral Maxillofac Pathol 21:425–428. https://doi.org/10.
4103/jomfp.JOMFP_180_16
12. Kakoti LM, Mahanta D, Sharma JD, Chowdhury Z (2018)
Clear-cell squamous cell carcinoma: an uncommon variant
of very common malignancy in the head and neck. Int J Oral
Health Sci 8:136–139. https://doi.org/10.4103/ijohs.ijohs_23_
18
13. Ramani P, Gheena S, Karunagaran M, Hannah R (2021) Clearcell variant of oral squamous cell carcinoma: a rare entity. J Oral
Maxillofac Pathol 25:S22–S26. https://doi.org/10.4103/jomfp.
JOMFP_295_20
14. Hasegawa K, Fujii S, Kurppa KJ, Maehara T, Oobu K, Nakamura S et al (2022) Clear cell squamous cell carcinoma of the
tongue exhibits characteristics as an undifferentiated squamous
13
Head and Neck Pathology (2023) 17:1026–1033
15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. cell carcinoma. Pathol Res Pract 235:153909. https://doi.org/
10.1016/j.prp.2022.153909
Mukkanwar RN, Palaskar S, Pawar R, Shah DR (2022) Clear
cell variant of oral squamous cell carcinoma: case report and
review. Autops Case Rep 12:e2021388. https://doi.org/10.4322/
acr.2021.388
Mahamad Apandi NI, Ramanathan A, Ismail SM, Ranganathan
K (2022) Do clear cell changes in oral squamous cell carcinoma
warrant it being recognised as a variant? Cureus 14:e25057.
https://doi.org/10.7759/cureus.25057
Samuels Y, Waldman T (2010) Oncogenic mutations of PIK3CA
in human cancers. Curr Top Microbiol Immunol 347:21–41.
https://doi.org/10.1007/82_2010_68
Peyssonnaux C, Eychène A (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 93:53–62. https://
doi.org/10.1016/s0248-4900(01)01125-x
Engelman JA (2009) Targeting PI3K signalling in cancer:
opportunities, challenges and limitations. Nat Rev Cancer
9:550–562. https://doi.org/10.1038/nrc2664
Marquard FE, Jücker M (2020) PI3K/AKT/mTOR signaling as
a molecular target in head and neck cancer. Biochem Pharmacol
172:113729. https://doi.org/10.1016/j.bcp.2019.113729
Ho AL, Brana I, Haddad R, Bauman J, Bible K, Oosting S et al
(2021) Tipifarnib in head and neck squamous cell carcinoma
with HRAS mutations. J Clin Oncol 39:1856–1864. https://doi.
org/10.1200/JCO.20.02903
Hori Y, Hirose K, Ozeki M, Hata K, Motooka D, Tahara S
et al (2022) PIK3CA mutation correlates with mTOR pathway
expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA). Diagn Pathol 17:19. https://
doi.org/10.1186/s13000-022-01199-3
Hirose K, Usami Y, Kohara M, Sato S, Iwamoto Y, Murakami
S et al (2021) Clear cell carcinoma of palatal minor salivary
gland harboring a novel EWSR1-ATF1 fusion gene: report of a
case and review of the literature. Head Neck Pathol 15:676–681.
https://doi.org/10.1007/s12105-020-01211-6
Janku F, Lee JJ, Tsimberidou AM, Hong DS, Naing A, Falchook
GS et al (2011) PIK3CA mutations frequently coexist with RAS
and BRAF mutations in patients with advanced cancers. PLoS
ONE 6:e22769. https://doi.org/10.1371/journal.pone.0022769
Agrawal N, Frederick MJ, Pickering CR, Bettegowda C,
Chang K, Li RJ et al (2011) Exome sequencing of head and
neck squamous cell carcinoma reveals inactivating mutations
in NOTCH1. Science 333:1154–1157. https://doi.org/10.1126/
science.1206923
Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K,
Sivachenko A et al (2011) The mutational landscape of head and
neck squamous cell carcinoma. Science 333:1157–1160. https://
doi.org/10.1126/science.1208130
Kobayashi K, Yoshimoto S, Matsumoto F, Ando M, Murakami
N, Omura G et al (2019) All-exon TP53 sequencing and protein phenotype analysis accurately predict clinical outcome
after surgical treatment of head and neck squamous cell carcinoma. Ann Surg Oncol 26:2294–2303. https://doi.org/10.1245/
s10434-019-07287-x
Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S,
Neskey DM et al (2013) Integrative genomic characterization
of oral squamous cell carcinoma identifies frequent somatic
drivers. Cancer Discov 3:770–781. https://d oi.o rg/1 0.1 158/
2159-8290.CD-12-0537
Cancer Genome Atlas Network (2015) Comprehensive genomic
characterization of head and neck squamous cell carcinomas.
Nature 517:576–582. https://doi.org/10.1038/nature14129
Starzyńska A, Sejda A, Adamska P, Marvaso G, SakowiczBurkiewicz M, Adamski Ł et al (2020) Prognostic value of the
PIK3CA, AKT, and PTEN mutations in oral squamous cell
Head and Neck Pathology (2023) 17:1026–1033 carcinoma: literature review. Arch Med Sci 17:207–217. https://
doi.org/10.5114/aoms.2020.100780
31. Chen SJ, Liu H, Liao CT, Huang PJ, Huang Y, Hsu A et al
(2015) Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic
gene signature. Oncotarget 6:18066–18080. https://doi.org/10.
18632/oncotarget.3768
3 2. Batta N, Pandey M (2019) Mutational spectrum of tobacco
associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol 17:198. https://doi.org/10.1186/
s12957-019-1741-2
1033
33. Coleman N, Marcelo KL, Hopkins JF, Khan NI, Du R, Hong
L et al (2023) HRAS mutations define a distinct subgroup in
head and neck squamous cell carcinoma. JCO Precis Oncol
7:e2200211. https://doi.org/10.1200/PO.22.00211
Publisher's Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Authors and Affiliations
Katsutoshi Hirose1 · Takumi Shibahara1,2 · Akari Teramoto1,2 · Yu Usami1 · Sawako Ono3 · Yuri Iwamoto4 ·
Shumei Murakami4 · Kaori Oya5 · Narikazu Uzawa2 · Daisuke Motooka6 · Yumiko Hori7,8 · Eiichi Morii7 ·
Satoru Toyosawa1
* Katsutoshi Hirose
hirose.katsutoshi.dent@osaka-u.ac.jp
Satoru Toyosawa
toyosawa.satoru.dent@osaka-u.ac.jp
Takumi Shibahara
u395284j@ecs.osaka-u.ac.jp
Department of Oral and Maxillofacial Pathology, Osaka
University Graduate School of Dentistry, 1‑8 Yamadaoka,
Suita, Osaka 565‑0871, Japan
Department of Oral & Maxillofacial Oncology and Surgery,
Osaka University Graduate School of Dentistry, 1‑8
Yamadaoka, Suita, Osaka 565‑0871, Japan
Department of Pathology and Medicine, Graduate School
of Medicine, Dentistry and Pharmaceutical Sciences,
Okayama University, Okayama 700‑8558, Japan
Department of Oral and Maxillofacial Radiology, Osaka
University Graduate School of Dentistry, 1‑8 Yamadaoka,
Suita, Osaka 565‑0871, Japan
Clinical Laboratory, Osaka University Dental Hospital, 1‑8
Yamadaoka, Suita, Osaka 565‑0871, Japan
Daisuke Motooka
daisukem@gen-info.osaka-u.ac.jp
Genome Information Research Center, Research Institute
for Microbial Diseases, Osaka University, 3‑1 Yamadaoka,
Suita, Osaka 565‑0871, Japan
Yumiko Hori
yumiko-hori@molpath.med.osaka-u.ac.jp
Department of Pathology, Osaka University Graduate School
of Medicine, 2‑2 Yamadaoka, Suita, Osaka 565‑0871, Japan
Department of Central Laboratory and Surgical Pathology,
National Hospital Organization, Osaka National Hospital,
2‑1‑14 Hoenzaka, Chuo‑ku, Osaka 540‑0006, Japan
Akari Teramoto
u970049j@ecs.osaka-u.ac.jp
Yu Usami
usami.yuu.dent@osaka-u.ac.jp
Sawako Ono
de19008@s.okayama-u.ac.jp
Yuri Iwamoto
nishikawa.yuri.dent@osaka-u.ac.jp
Shumei Murakami
murakami.shumei.dent@osaka-u.ac.jp
Kaori Oya
ooya.kaori.dent@osaka-u.ac.jp
Narikazu Uzawa
uzawa.narikazu.dent@osaka-u.ac.jp
Eiichi Morii
morii@molpath.med.osaka-u.ac.jp
13
...
論文の公開元へ
